# Modulating Socially Adaptive Mirror System Functioning in Autism by Oxytocin

> **NCT03640156** · PHASE3 · COMPLETED · sponsor: **KU Leuven** · enrollment: 25 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Oxytocin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03640156
- **Lead sponsor:** KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-26
- **Primary completion:** 2019-12-19
- **Final completion:** 2019-12-19
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03640156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03640156, "Modulating Socially Adaptive Mirror System Functioning in Autism by Oxytocin". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03640156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*